Prognostic factors and outcomes of adjuvant and first-line metastatic treatments in melanoma a Turkish oncology group study.
Majidova N, Arak H, Ozalp FR, Bas O, Koker GO, Ozmarasalı EB, Karateke YS, Sakalar T, Yaslikaya S, Onur ID, Akdag G, Ogul A, Guliyev M, Sahin E, Delipoyraz EE, Alkan A, Aydın O, Ilhan N, Alan O, Akbas S, Cağlar Y, Guren AK, Sever N, Ellez HI, Selcukbiricik F, Muhammed Atcı M, Bilici A, Demirci NS, Basoglu T, Karacin C, Kara IO, Yıldız B, Evrensel T, Karaca M, Dizdar O, Atag E, Ozgun A, Kostek O.
Majidova N, et al. Among authors: yildiz b.
Sci Rep. 2025 Jan 25;15(1):3200. doi: 10.1038/s41598-025-87553-z.
Sci Rep. 2025.
PMID: 39863702
Free PMC article.